H.C. Wainwright Reiterates Buy Rating on FibroGen (FGEN)
Tweet Send to a Friend
H.C. Wainwright analyst Matt Keller reiterated a Buy rating and $43.00 price target on FibroGen (NASDAQ: FGEN).The analyst commented: "FibroGen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
